OpenVSafe by OpenVAERS
Search V-safe

ZDV-11701-20421

5 vaccinations 18 coded responses 61 check-ins 17 free-text entries 1 call case
Sex
Female
Age at first dose
66+
ZIP prefix
496 / MI
Registered
2020-12-29
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Registered in v-safe
  2. 2020-12-29
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-29
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  5. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  7. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Muscle or body aches
    Adult check-in
  10. 2021-01-05
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-14
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-19
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-19
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-01-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  15. 2021-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain
    Adult check-in
  16. 2021-01-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain
    Adult check-in
  17. 2021-01-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain
    Adult check-in
  18. 2021-01-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Abdominal pain
    Adult check-in
  19. 2021-01-26
    Health check-in — day 7, dose 2
    Feeling: Fair · Headache, Joint pains, Muscle or body aches
    Adult check-in
  20. 2021-02-02
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-09
    Survey response — day 21, dose 2
    MedDRA: Abdominal discomfort, Diarrhoea — Feeling: Good
    Free text: Some GI distress including loose stools.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-02-16
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-23
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-02
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-20
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-10-04
    Dose 3 — Pfizer-BioNTech
  28. 2021-10-04
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  29. 2021-10-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Chills, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  30. 2021-10-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Chills, Abdominal pain
    Adult check-in
  31. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  32. 2021-10-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, Abdominal pain
    Adult check-in
  33. 2021-10-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache, Abdominal pain
    Adult check-in
  34. 2021-10-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  35. 2021-10-11
    Health check-in — day 7, dose 3
    Feeling: Good · Headache, Nausea
    Adult check-in
  36. 2021-10-18
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-10-25
    Survey response — day 21, dose 3
    MedDRA: Headache, Nausea, Pyrexia — Feeling: Fair · Be unable to work or attend school
    Free text: Headache, nausea, and low grade fever
    MedDRA releases: 2024-11 · check-in free text available
  38. 2021-11-01
    Survey response — day 28, dose 3
    MedDRA: Body temperature increased — Feeling: Good
    Free text: Periodic short lasting low grade fevers of ~ 100.
    MedDRA releases: 2024-11 · check-in free text available
  39. 2021-11-08
    Survey response — day 35, dose 3
    MedDRA: Fatigue, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair
    Free text: Very sore throat and some head congestion; fatigue
    MedDRA releases: 2024-11 · check-in free text available
  40. 2021-11-15
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  41. 2022-01-03
    Survey response — 3 months, dose 3
    MedDRA: Oropharyngeal pain, Sinusitis — Feeling: Fair
    Free text: Probable lingering sinus infection; sore throat
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-04-04
    Survey response — 6 months, dose 3
    MedDRA: Pre-existing disease, Tinnitus — Feeling: Good
    Free text: Existing tinnitus has exacerbated
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-04-27
    Dose 4 — Pfizer-BioNTech
  44. 2022-04-29
    Survey response — days 1–6 daily, dose 4
    MedDRA: Adverse reaction — Feeling: Good · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Free text: These were significant in the first 24-36 hours
    MedDRA releases: 2024-11 · check-in free text available
  45. 2022-04-30
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · Headache, Joint pains
    Adult check-in
  46. 2022-05-01
    Survey response — days 1–6 daily, dose 4
    MedDRA: Epistaxis — Feeling: Fair · Site: Pain · Fever · Headache
    Free text: Nose bleed
    MedDRA releases: 2024-11 · check-in free text available
  47. 2022-05-02
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Headache
    Adult check-in
  48. 2022-05-03
    Survey response — days 1–6 daily, dose 4
    MedDRA: Oropharyngeal pain — Feeling: Good
    Free text: Slight sore throat
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-05-04
    Health check-in — day 7, dose 4
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  50. 2022-05-11
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  51. 2022-05-18
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  52. 2022-05-26
    Survey response — day 28, dose 4
    MedDRA: Cough — Feeling: Good
    Free text: Dry cough
    MedDRA releases: 2024-11 · check-in free text available
  53. 2022-06-01
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  54. 2022-06-08
    Survey response — day 42, dose 4
    MedDRA: Epistaxis — Feeling: Good
    Free text: Another spontaneous nosebleed.
    MedDRA releases: 2024-11 · check-in free text available
  55. 2022-07-27
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  56. 2022-10-26
    Survey response — 6 months, dose 4
    MedDRA: Epistaxis — Feeling: Fair
    Free text: Occasional unprovoked nosebleeds.
    MedDRA releases: 2024-11 · check-in free text available
  57. 2022-11-10
    Dose 5 — Pfizer-BioNTech
  58. 2022-11-15
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Pain · None
    Adult check-in
  59. 2022-11-16
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  60. 2022-11-17
    Health check-in — day 7, dose 5
    Feeling: Fair · Fever · Headache, Fatigue or tiredness
    Adult check-in
  61. 2022-11-24
    Survey response — day 14, dose 5
    MedDRA: Fatigue, Oropharyngeal pain — Feeling: Fair
    Free text: Sore throat and fatigue
    MedDRA releases: 2024-11 · check-in free text available
  62. 2022-12-01
    Survey response — day 21, dose 5
    MedDRA: Epistaxis, Oropharyngeal pain, Pyrexia — Feeling: Fair
    Free text: Sore throat. Short lived fevers. I continue to have weekly unprovoked nosebleeds.
    MedDRA releases: 2024-11 · check-in free text available
  63. 2022-12-08
    Survey response — day 28, dose 5
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good
    Free text: Nose bleeds are more frequent.
    MedDRA releases: 2024-11 · check-in free text available
  64. 2022-12-15
    Survey response — day 35, dose 5
    MedDRA: Epistaxis — Feeling: Good
    Free text: Nosebleeds continue and are more frequent.
    MedDRA releases: 2024-11 · check-in free text available
  65. 2022-12-22
    Survey response — day 42, dose 5
    MedDRA: Gastrointestinal disorder, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair
    Free text: Moderate sore throat and congestion, some GI issues.
    MedDRA releases: 2024-11 · check-in free text available
  66. 2023-02-09
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  67. 2023-05-11
    Survey response — 6 months, dose 5
    MedDRA: COVID-19, Cough, Diarrhoea, Dyspnoea, Epistaxis, Fatigue, Oropharyngeal pain, Pain, Parosmia, Pyrexia, Respiratory tract congestion, Sneezing, Taste disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  68. 2023-05-11
    Report sent to call center — 6 months, dose 5
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  69. 2023-05-12

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Pfizer-BioNTech
22021-01-19Pfizer-BioNTech
32021-10-04Pfizer-BioNTech No
42022-04-27Pfizer-BioNTech No
52022-11-10Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2023-05-11 Unsuccessful

Free text

Release 3 — day 21, dose 2

2021-02-09

Symptoms: Some GI distress including loose stools.

Release 10 — day 21, dose 3

2021-10-25

Symptoms: Headache, nausea, and low grade fever

Release 10 — day 28, dose 3

2021-11-01

Symptoms: Periodic short lasting low grade fevers of ~ 100.

Release 10 — day 35, dose 3

2021-11-08

Symptoms: Very sore throat and some head congestion; fatigue

Release 10 — 3 months, dose 3

2022-01-03

Symptoms: Probable lingering sinus infection; sore throat

Release 11 — 6 months, dose 3

2022-04-04

Symptoms: Existing tinnitus has exacerbated

Release 11 — days 1–6 daily, dose 4

2022-04-29

Systemic reaction (other): These were significant in the first 24-36 hours

2022-05-01

Systemic reaction (other): Nose bleed

2022-05-03

Systemic reaction (other): Slight sore throat

Release 11 — day 28, dose 4

2022-05-26

Symptoms: Dry cough

Release 11 — day 42, dose 4

2022-06-08

Symptoms: Another spontaneous nosebleed.

Release 12 — 6 months, dose 4

2022-10-26

Symptoms: Occasional unprovoked nosebleeds.

Release 12 — day 14, dose 5

2022-11-24

Symptoms: Sore throat and fatigue

Release 12 — day 21, dose 5

2022-12-01

Symptoms: Sore throat. Short lived fevers. I continue to have weekly unprovoked nosebleeds.

Release 12 — day 28, dose 5

2022-12-08

Symptoms: Nose bleeds are more frequent.

Release 12 — day 35, dose 5

2022-12-15

Symptoms: Nosebleeds continue and are more frequent.

Release 12 — day 42, dose 5

2022-12-22

Symptoms: Moderate sore throat and congestion, some GI issues.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal discomfort ✓ ✓ ✓
SDBody temperature increased · · ✓
SDCondition aggravated · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDiarrhoea ✓ ✓ ✓
SDDyspnoea · · ✓
SDEpistaxis · · ✓
SDFatigue · · ✓
SDGastrointestinal disorder · · ✓
SDHeadache · · ✓
SDNausea · · ✓
SDOropharyngeal pain · · ✓
SDPain · · ✓
SDParosmia · · ✓
SDPre-existing disease · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDSinusitis · · ✓
SDSneezing · · ✓
SDTaste disorder · · ✓
SDTinnitus · · ✓
SROAdverse reaction · · ✓
SROEpistaxis · · ✓
SROOropharyngeal pain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release